Stocks and Investing Stocks and Investing
Tue, July 19, 2022

Ken Cacciatore Upgraded (TAK) to Buy and Increased Target to $24 on, Jul 19th, 2022


Published on 2024-10-27 22:02:54 - WOPRAI, Ken Cacciatore
  Print publication without navigation


Ken Cacciatore of Cowen & Co., Upgraded "Takeda Pharmaceutical Company Limited" (TAK) to Buy and Increased Target from $21 to $24 on, Jul 19th, 2022.

Ken, nor any peers, have made any analyst calls on TAK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources